What Happened?
Vancouver, WA-based CytoDyn Appointed Nitya Ray as Chief Technology Officer
Vancouver, WA-based CytoDyn Appointed Nitya Ray as Chief Technology Officer
CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection. We have one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which prevents viral entry into healthy T-cells by blocking the HIV co-receptor CCR5. The drug candidate is also being tested for other immunological conditions, and has been granted FDA orphan drug status for the treatment of Graft versus Host Disease (GvHD) in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation.
Nitya Ray is Chief Technology Officer at CytoDyn. Previously, Nitya held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Germeys Philip, Hunter Doak, Weber Donald, Wood John, Rago Peter, Vijayarajendran Priya, Van Wassen Kari, Eskew Jason, Manda Srikant, Box Justin, Berg Johanna
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.